Market Overview

UPDATE: Oppenheimer Raises PT to $37 on Oracle Following Positive Q2 Results

Share:
Related ORCL
Most Of Credit Suisse's Top Investment Ideas For 2016...In One Place
25 Companies That Could Still Buy Back Mountains Of Stock
Cisco, IBM, Dell M&A Brawl May Whack Symantec, Palo Alto, Fortinet (Investor's Business Daily)

Oppenheimer reiterated its Outperform rating on Oracle (NASDAQ: ORCL) and increased its price target from $36 to $37.

Oppenheimer said, "We believe Oracle's internally-driven new product-cycles are gaining traction within the base, and as the uptake becomes more meaningful (over the next 12-18 months) it should start yielding greater operating leverage and serve as a catalyst to drive a revaluation of the stock multiple."

Oracle closed at $32.88 on Tuesday.

Latest Ratings for ORCL

DateFirmActionFromTo
Jan 2016BMO CapitalInitiates Coverage onMarket Perform
Jan 2016Evercore ISI GroupUpgradesHoldBuy
Nov 2015Goldman SachsUpgradesBuyConviction Buy

View More Analyst Ratings for ORCL
View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Price Target Pre-Market Outlook Analyst Ratings

 

Related Articles (ORCL)

View Comments and Join the Discussion!

Get Benzinga's Newsletters